If you are concerned about frothy growth stock valuations, the contrarian “Dogs of The Dow” strategy is something you may want to consider. This report dives deep into the current “dogs” sharing all kinds of data worth considering and then reviews UnitedHealth Group in detail (i.e. one particularly interesting current “Dog of The Dow”). Enjoy!
UnitedHealth Group: Post 50% Decline, Shares Worth Considering
UnitedHealth Group, a stalwart Dow Jones component and important part of the healthcare sector, is trading 50% below recent all-time highs due to operational challenges (they pulled guidance), regulatory scrutiny (the DOJ is probing potential Medicare Advantage fraud) and leadership changes. This report reviews the business, growth, capital allocation, valuation and risks, and then concludes with my strong opinion on investing.